Clinical Trial to Test Stem Cells Against Type 1 Diabetes
December 9, 2019
(UPI) – Having type 1 diabetes can lead to crippling complications over time — and a cure remains elusive. However, researchers at the Medical University of South Carolina, or MUSC, are leading research efforts into the use of mesenchymal stem cells, or MSCs, to rein in or even reverse its debilitating effects, researchers announced this week. They are currently enrolling people with type 1 diabetes in a clinical study to learn whether MSCs from umbilical cords transplanted into the pancreases of the disease can help their bodies produce insulin.